MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KROS has $338,021K in assets. $34,889K in debts. $287,415K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1545.18%
Quick Ratio
1545.18%
Cash Ratio
1407.93%
Debt to Asset Ratio
10.32%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Treasury stock, at cost 21,126,7...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
287,415
Accounts receivable
3,567
Prepaid expenses and other current assets
22,202
Current income tax receivable
2,250
Total current assets
315,434
Operating lease right-of-use assets
16,841
Property and equipment, net
4,297
Restricted cash
1,449
Other long term assets
0
Total assets
338,021
Accounts payable
1,967
Accrued expenses and other current liabilities
16,039
Current portion of operating lease liabilities
2,408
Total current liabilities
20,414
Operating lease liabilities, net of current portion
14,475
Total liabilities
34,889
Common stock, par value of 0.0001 per share 200,000,000 shares authorized as of december31, 2025 and december31, 2024 40,670,466 shares issued and 19,543,706 shares outstanding as of december31, 2025 and 40,554,705 shares issued and outstanding as of december31, 2024
4
Treasury stock, at cost 21,126,760 and no shares as of december31, 2025 and december31, 2024, respectively
384,558
Additional paid-in capital
1,169,451
Accumulated deficit
-481,765
Total stockholders equity
303,132
Total liabilities and stockholders equity
338,021
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$287,415K Prepaid expenses andother current assets$22,202K Accounts receivable$3,567K Current income taxreceivable$2,250K Total current assets$315,434K Operating leaseright-of-use assets$16,841K Property and equipment,net$4,297K Restricted cash$1,449K Total assets$338,021K Total liabilities andstockholders equity$338,021K Total stockholdersequity$303,132K Total liabilities$34,889K Accumulated deficit-$481,765K Treasury stock, at cost21,126,760 and no shares as...$384,558K Additional paid-in capital$1,169,451K Total currentliabilities$20,414K Operating leaseliabilities, net of current...$14,475K Common stock, par valueof 0.0001 per share...$4K Accrued expenses andother current...$16,039K Current portion ofoperating lease...$2,408K Accounts payable$1,967K

Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. (KROS)